Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
32.0 |
% |
32 |
% |
PO, oral; immediate release formulation; |
DRUGBANK |
Bioavailability |
32.0 |
% |
32 |
% |
PO, oral; extended release formulation; |
DRUGBANK |
C Max |
64.2 |
ng/ml |
64.2 |
ng/ml |
PO, oral; immediate release formulation; |
DRUGBANK |
C Max |
22.5 |
ng/ml |
22.5 |
ng/ml |
PO, oral; extended release formulation; |
DRUGBANK |
T Max |
1.5 |
h |
1.5 |
h |
PO, oral; immediate release formulation; |
DRUGBANK |
T Max |
5.0 |
h |
5.0 |
h |
PO, oral; extended release formulation; |
DRUGBANK |
Metabolic |
97.0 |
% |
97 |
% |
Inactive metabolite; |
DRUGBANK |
Clearance |
91.8 |
L/h |
1530 ± 177 |
ml/min |
Total clearance; |
DRUGBANK |
Clearance |
1.3 |
L/h/kg |
21.33 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
540.0 |
L |
540±98 |
L |
intravenous injection, IV; |
DRUGBANK |
Volume of Distribution |
4.6 |
L/kg |
4.64 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
4.0 |
h |
4 |
h |
elimination half-life; intravenous injection, IV; |
DRUGBANK |
Half-life |
2.4 |
h |
2.39 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
3200.0 |
mg/kg |
3200.0 |
mg/kg |
PO, oral; rabbit; |
DRUGBANK |
Toxicity LD50 |
300.0 |
mg/kg |
300.0 |
mg/kg |
PO, oral; mouse; |
DRUGBANK |
Toxicity LD50 |
980.0 |
mg/kg |
980.0 |
mg/kg |
PO, oral; Rattus, Rat; |
DRUGBANK |
Eliminate Route |
99.0 |
% |
99 |
% |
Urinary excretion; |
DRUGBANK |
Eliminate Route |
3.0 |
% |
3 |
% |
Urinary excretion; Unchanged drug; |
DRUGBANK |
Protein Binding |
20.0 |
% |
~20 |
% |
|
DRUGBANK |